Literature DB >> 27308596

MicroRNAs-from metastasis prediction to metastasis prevention?

Mohammed Abba1, Nitin Patil1, Jörg Hendrik Leupold1, Heike Allgayer1.   

Abstract

Recently, we suggested the microRNA (miR) landscape defining metastasis. The first miR-driven network orchestrating invasion, intravasation, and metastasis was confirmed independently across several malignancies, suggesting a rather general principle for metastasis regulation. We hope that our data will stimulate the field in terms of further hypothesis generation, metastasis prediction, and metastasis prevention.

Entities:  

Keywords:  Cancer; EMT; FOXN3; metastasis; microRNA; stem cell

Year:  2015        PMID： 27308596      PMCID： PMC4905395          DOI： 10.1080/23723556.2015.1074336

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  7 in total

1.  A Systematic Approach to Defining the microRNA Landscape in Metastasis.

Authors:  Giridhar Mudduluru; Mohammed Abba; Jasmin Batliner; Nitin Patil; Maike Scharp; Taral R Lunavat; Jörg Hendrik Leupold; Olga Oleksiuk; Dilafruz Juraeva; Wilko Thiele; Melanie Rothley; Axel Benner; Yinon Ben-Neriah; Jonathan Sleeman; Heike Allgayer
Journal:  Cancer Res       Date:  2015-06-11       Impact factor: 12.701

2.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Authors:  Daniel R Rhodes; Shanker Kalyana-Sundaram; Vasudeva Mahavisno; Radhika Varambally; Jianjun Yu; Benjamin B Briggs; Terrence R Barrette; Matthew J Anstet; Colleen Kincead-Beal; Prakash Kulkarni; Sooryanaryana Varambally; Debashis Ghosh; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

3.  MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.

Authors:  Ching-Wen Lin; Yih-Leong Chang; Yu-Chiuan Chang; Jau-Chen Lin; Chun-Chi Chen; Szu-Hua Pan; Chen-Tu Wu; Hsuan-Yu Chen; Shuenn-Chen Yang; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 4.  The pre-metastatic niche: finding common ground.

Authors:  Jaclyn Sceneay; Mark J Smyth; Andreas Möller
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

5.  The shaping and functional consequences of the microRNA landscape in breast cancer.

Authors:  Heidi Dvinge; Anna Git; Stefan Gräf; Mali Salmon-Divon; Christina Curtis; Andrea Sottoriva; Yongjun Zhao; Martin Hirst; Javier Armisen; Eric A Miska; Suet-Feung Chin; Elena Provenzano; Gulisa Turashvili; Andrew Green; Ian Ellis; Sam Aparicio; Carlos Caldas
Journal:  Nature       Date:  2013-05-05       Impact factor: 49.962

6.  MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

Authors:  Nicola Valeri; Chiara Braconi; Pierluigi Gasparini; Claudio Murgia; Andrea Lampis; Viola Paulus-Hock; Jonathan R Hart; Lynn Ueno; Sergei I Grivennikov; Francesca Lovat; Alessio Paone; Luciano Cascione; Khlea M Sumani; Angelo Veronese; Muller Fabbri; Stefania Carasi; Hansjuerg Alder; Giovanni Lanza; Roberta Gafa'; Mary P Moyer; Rachel A Ridgway; Julia Cordero; Gerard J Nuovo; Wendy L Frankel; Massimo Rugge; Matteo Fassan; Joanna Groden; Peter K Vogt; Michael Karin; Owen J Sansom; Carlo M Croce
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

Review 7.  miR-34: from bench to bedside.

Authors:  Massimiliano Agostini; Richard A Knight
Journal:  Oncotarget       Date:  2014-02-28
  7 in total
  3 in total

1.  Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.

Authors:  Wei Chen; Yi Liu; Hongde Chen; Hao Ning; Kejia Ding
Journal:  Int J Oncol       Date:  2017-06-12       Impact factor: 5.650

2.  MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer.

Authors:  Xi Chao Wei; Zhong Hua Lv
Journal:  Onco Targets Ther       Date:  2019-07-23       Impact factor: 4.147

3.  Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma.

Authors:  Esther K Elliott; Lloyd N Hopkins; Robert Hensen; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.